CD38: The Dots Are Real, The Line Is Preclinical

The mechanism, told properly — because it's genuinely interesting

The CD38 story deserves an accurate telling before its honest sizing: the biology — NAD is a coenzyme central to cellular energy metabolism and repair signalling, its levels decline with age, and CD38 is one of the enzymes that consumes it: an axis genuinely studied across the ageing-biology field; the apigenin connection — laboratory work shows apigenin inhibiting CD38 in cell and animal models, with downstream NAD effects in those systems: real preclinical science, properly published, legitimately interesting (the existing page this deepens, the molecule); and the culture — longevity-podcast ecosystems connected those dots into stack recommendations, which is how a chamomile flavone acquired an ageing chapter. The dots are real; this page's whole job is sizing the line between them.

The sizing — where the story stops, and why that matters

The honest gap, stated without hostility to the research: human NAD outcomes for apigenin remain essentially unmeasured — no trials showing oral apigenin raising human NAD, no dose-response in people, no functional endpoints downstream: the story currently stops at the bench, and 'inhibits CD38 in models' sits several expensive research years from 'preserves your NAD' (the audit's registers, the absorption questions that complicate the leap). Why the sizing matters practically: no longevity claims exist and none may be worn — so a purchase made for the NAD story is a purchase made on preclinical mechanism, the category's classic overreach, and this label declines to sell it that way: Futuro Labs Apigenin is positioned at the evening where its small human file sits, with the CD38 chapter filed honestly as research-in-progress (the longevity page's same discipline, the record).

Sold for the evening file, not the bench story — research labelled as research

Futuro Labs Apigenin

★ 5/5

£19.99 for 90 capsules (90 days) · ~22p per day

50mg apigenin per vegan capsule at 98% independently verified purity — two ingredients total, UK GMP manufactured, per-batch micro and heavy-metal testing shown.

Pros

• 50mg per capsule — the wind-down convention's dose, one capsule, no splitting
• 98% purity independently verified — rare in a category that mostly asserts it
• Two ingredients (apigenin + rice flour) in a vegan HPMC capsule — no filler stack
• Per-batch testing shown: 5 microbiological + 4 heavy-metal checks, all passing
• 90-day supply at ~22p/night

Cons

• No authorised claims exist for apigenin — this is a research-stage molecule sold honestly or not at all
• Drowsiness is the relevant effect: no driving until you know your response; medication users need the pharmacist minute first

Available from: Amazon UK — £19.99

What actually supports ageing well — and the close

The canon the longevity aisle competes against, printed as ever: exercise — the best-evidenced metabolic and healthspan intervention available, resistance and cardio both, no molecule close; sleep sufficiency — the nightly repair window this cluster's honest territory serves; not smoking, sensible weight, alcohol moderation — the unglamorous triad carrying decades of outcome data; and the screening conversations by age — blood pressure known, invitations accepted: the GP's calendar beats the biohacker's stack on the evidence every time. For the reader who enjoys the research anyway: following the CD38 literature is a legitimate hobby — this page just insists the reading and the buying stay separate decisions, and the research summary keeps the file honest as it grows. Gates as ever: drowsiness → evening-only, no driving after; any medication → the pharmacist minute; pregnancy or nursing → GP, pharmacist or midwife first (the drowsiness and driving note, the pharmacist gate). CD38, NAD and apigenin, closed at the bench where the story lives: real enzymology, honestly credited — and a gap between models and men that no marketing may quietly delete.

Frequently asked questions